Veterinary Medicines

Advantage 80 mg spot-on solution for cats and pet rabbits (≥4 kg)

Authorised
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Advantage 80 mg Lösung zum Auftropfen auf die Haut für große Katzen und große Zierkaninchen
Advantage 80 mg spot-on solution for cats and pet rabbits (≥4 kg)
Active substance:
  • Imidacloprid
Target species:
  • Cat
  • Rabbit
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    10.00
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Cat
    • Rabbit
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Pack sizes 0.8 ml solution per pipette, Blister pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.8 ml solution per pipette, Blister pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.8 ml solution per pipette, Blister pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.8 ml solution per pipette, Blister pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma + Veterinär Produkte GmbH
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22020/052/002
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0022/002
Concerned member states:
  • France
  • Germany
  • Ireland
  • Italy
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."